1. McAllister SC, Schleiss MR. Prospects and perspectives for development of a vaccine against herpes simplex virus infections. Expert review of vaccines. 2014;13(11):1349-60.
2. Suazo PA, Ibañez FJ, Retamal-Díaz AR, Paz-Fiblas MV, Bueno SM, Kalergis AM, et al. Evasion of early antiviral responses by herpes simplex viruses. Mediators of inflammation. 2015;2015.
3. Knipe D, Howley P. Fields virology. ed. t, editor: Lippincott Williams and Wilkins; 2013.
4. Jiang Y-C, Feng H, Lin Y-C, Guo X-R. New strategies against drug resistance to herpes simplex virus. International journal of oral science. 2016;8(1):1-6.
5. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Archives of internal medicine. 2008;168 (11):1137-1144.
6. Ghannadi A, Fattahian K, Shokoohinia Y, Behbahani M, Shahnoush A. Anti-viral evaluation of sesquiterpene coumarins from Ferula assa-foetida against HSV-1. Iranian journal of pharmaceutical research: IJPR. 2014;13(2):523.
7. Karimi A, Moradi MT, Saedi M, Salimzadeh L, Rafieian-Kopaei M. The Inhibitory Effects of Eucalyptus Extract on Herpes Simplex Virus-1 Replication in Baby Hamster Kidney Cells. Qom Univ Med Sci J. 2012; 6:3–8 (article in Persian).
8. Gilca M, Gaman L, Panait E, Stoian I, Atanasiu V. Chelidonium majus–an integrative review: traditional knowledge versus modern findings. Forschende Komplementärmedizin/Research in Complementary Medicine. 2010;17(5):241-8.
9. Zarei A, Changizi Ashtiyani S, Rezaei A, Nabi Abdolyousefi N, Ghosemi A. The Experimental Study of the Effect of Hydroalcoholic Extracts of Chelidonium majus on Liver Function Tests and Renal in Rats with Hypercholesterolemia. AJP 2013; 4(48): 117-25.
10. Ghorbanli M, Fani P, Sateei A. Seasonal changes of alkaloids and phenolic compounds in Chelidonium Majus L. in two habitats. Journal of Plant Environmental Physiology 2009; 3, 4(15); (article in Persian)
11. Jyoti BS. Chelidonium majus L.-a review on pharmacological activities and clinical effects. Global Journal of Research on Medicinal Plants & Indigenous Medicine. 2013; 2(4):238.
12. Arora D, Sharma A. A review on phytochemical and pharmacological potential of genus Chelidonium. Pharmacognosy Journal. 2013;5(4):184-90.
13. Kukhanova M, Korovina A, Kochetkov S. Human herpes simplex virus: life cycle and development of inhibitors. Biochemistry (Moscow). 2014;79(13):1635-52.
14. Andrei G, Snoeck R. Herpes simplex virus drug-resistance: new mutations and insights. Current opinion in infectious diseases. 2013;26(6):551-60.
15. Monavari SH, Shahrabadi MS, Keyvani H, Bokharaei-Salim F. Evaluation of in vitro antiviral activity of Chelidonium majus L. against herpes simplex virus type-1. African Journal of Microbiology Research. 2012; 6(20):4360-4.
16. Monavari H, Hamkar R, Norooz-Babaei Z, Adibi L, Noroozi M, Ziaei A. Antiviral effect assay of twenty-five species of various medicinal plants families in Iran. Iran J Med Microbiol 2007; 1(2): 49-59. (Article in Persian)
17. Sadeghpour Natanzi M, Parsania M, Aminzadeh M. Antiviral and virucidal activity of Chelidonium majus L. extract compared with Acyclovir against Herpes simplex virus type 1. Armaghanedanesh 2017; 21 (11): 1056-1068. (Article in Persian)
18. Gerenˇcer M., Turecek Pl., Kistner O., Mitterer A., Savidis-Dacho H., Barrett N P. In vitro and in vivo anti-retroviral activity of the substance purifiedfrom the aqueous extract of Chelidonium majus L. Antiviral research, 72 (2006) 153-156.
19. El-Mekkawy S., Abdel-Sattar E., Hattori M., Takuya K., Toru O. Screening of medicinal plants in Egypt for Anti-Human Immunodeficiency Virus Type-1(HIV-1) activity. JASMR.2009; 4(1): 1-8.